Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 2, 2009, Pages

  Gruchalla, Rebecca S ^a   Sampson, Hugh A ^b   Matsui, Elizabeth ^c   David, Gloria ^d   Gergen, Peter J ^e   Calatroni, Agustin ^d   Brown, Mark ^f   Liu, Andrew H ^g,h   Bloomberg, Gordon R ⁱ   Chmiel, James F ^j   Kumar, Rajesh ^k   Lamm, Carin ^l   Smartt, Ernestine ^e   Sorkness, Christine A ^m   Steinbach, Suzanne F ⁿ   Stone, Kelly D ^o   Szefler, Stanley J ^g,p   Busse, William W ^m  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RHO INC   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^g DEPARTMENT OF MEDICINE   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ WASHINGTON UNIVERSITY   (United States)

^j CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k CHILDREN'S MEMORIAL HOSPITAL   (United States)

^l Columbia University College of Physicians and Surgeons ^*  (United States)

^m UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

ⁿ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^p UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

airway inflammation; allergic sensitization; Asthma; asthma severity; exhaled nitric oxide; inner city

Indexed keywords

FLUTICASONE; IMMUNOGLOBULIN E; MONTELUKAST; NITRIC OXIDE; SALBUTAMOL; SALMETEROL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BLOOD; CHILD; CITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; HEALTH CARE; HIGH RISK POPULATION; HUMAN; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESIDENTIAL AREA; RISK; SCHOOL CHILD; SENSITIZATION; SKIN ALLERGY; SKIN TEST; SPIROMETRY; SPUTUM CULTURE; TREATMENT DURATION;

EID: 67651211463     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.05.036     Document Type: Article

References (42)

1. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-summary. August 28, 2007. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf 2007. Accessed August 28, 2007.
2. Busse W.W., and Lemanske Jr. R.F. Expert Panel Report 3: Moving forward to improve asthma care. J Allergy Clin Immunol 120 (2007) 1012-1014
3. Szefler S.J., Mitchell H., Sorkness C.A., Gergen P.J., O'Connor G.T., Morgan W.J., et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 372 (2008) 1065-1072
4. Silkoff P.E., McClean P.A., Slutsky A.S., Furlott H.G., Hoffstein E., Wakita S., et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 155 (1997) 260-267
5. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 160 (1999) 2104-2117
6. Silkoff P.E., Carlson M., Bourke T., Katial R., Ogren E., and Szefler S.J. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol 114 (2004) 1241-1256
7. Fahy J., Boushey H., Lazarus S., Mauger E., Reuben M., Cherniak R., et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 163 (2001) 1470-1475
8. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 26 (2005) 319-338
9. Strunk R.C., Szefler S.J., Phillips B.R., Zeiger R.S., Chinchilli V.M., Larsen G., et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 112 (2003) 883-892
10. Evans III R., Gergen P.J., Mitchell H., Kattan M., Kercsmar C., Crain E., et al. A randomized clinical trial to reduce asthma morbidity among inner-city children: results of the National Cooperative Inner-City Asthma Study. J Pediatr 135 (1999) 332-338
11. Morgan W.J., Crain E.F., Gruchalla R.S., O'Connor G.T., Kattan M., Evans III R., et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 351 (2004) 1068-1080
12. Gromping U. Estimators of relative importance in linear regression based on variance decomposition. Am Stat 61 (2007) 139-147
13. R. Development Core Team. R: a language and environment for statistical computing (2007), R Foundation for Statistical Computing, Vienna, Austria
14. Gromping U. Relative importance for linear regression in R: the package relaimpo. J Stat Softw 17 (2006) 1-27
15. Djukanovic R., Wilson S.J., Kraft M., Jarjour N.N., Steel M., Chung K.F., et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 170 (2004) 583-593
16. Miller M.K., Lee J.H., Miller D.P., and Wenzel S.E. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 101 (2007) 481-489
17. Kwong K.Y.C., Morphew T., Scott L., Guterman J., and Jones C.A. Asthma control and future asthma-related morbidity in inner city asthmatic children. Ann Allergy Asthma Immunol 101 (2008) 144-152
18. Sullivan S.D., Wenzel S.E., Bresnahan B.W., Zheng B., Lee J.H., Pritchard M., et al. Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy 62 (2007) 655-660
19. Connolly C.K., Mamun M., Alcock S.M., and Prescott R.J. The Darlington and Northallerton Prospective Asthma Study: best function predicts mortality during the first 10 years. Respir Med 92 (1998) 1274-1280
20. Gelb A.F., Flynn Taylor C., Shinar C.M., Gutierrez C., and Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 129 (2006) 1492-1499
21. Belessis Y., Dixon S., Thomsen A., Duffy B., Rawlinson W., Henry R., et al. Risk factors for an intensive care unit admission in children with asthma. Pediatr Pulmonol 37 (2004) 201-209
22. Harkins M.S., Fiato K.L., and Iwamoto G.K. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 41 (2004) 471-476
23. Gruchalla R.S., Pongracic J., Plaut M., Evans III R., Visness C.M., Walter M., et al. Inner City Asthma Study: Relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol 115 (2005) 478-485
24. Rosenstreich D., Eggleston P., Kattan M., Baker D., Slavin R., Gergen P., et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 336 (1997) 1356-1363
25. Sporik R., Platts-Mills T.A., and Cogswell J.J. Exposure to house dust mite allergen of children admitted to hospital with asthma. Clin Exp Allergy 23 (1993) 740-746
26. Eisner M.D., Katz P.P., Lactao G., and Iribarren C. Impact of depressive symptoms on adult asthma outcomes. Ann Allergy Asthma Immunol 94 (2005) 566-574
27. Adams R.J., Smith B.J., and Ruffin R.E. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 55 (2000) 566-573
28. Deykin A., Lazarus S.C., Fahy J.V., Wechsler M.E., Boushey H.A., Chinchilli V.M., et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 115 (2005) 720-727
29. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 360 (2002) 1715-1721
30. Lex C., Jenkins G., Wilson N.M., Zacharasiewicz A., Erin E., Hansel T.T., et al. Does sputum eosinophilia predict the response to systemic corticosteroids in children with difficult asthma?. Pediatr Pulmonol 42 (2007) 298-303
31. Lex C., Ferreira F., Zacharasiewicz A., Nicholson A.G., Haslam P.L., Wilson N.M., et al. Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med 174 (2006) 1286-1291
32. Zacharasiewicz A., Wilson N., Lex C., Erin E.M., Li A.M., Hansel T., et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 171 (2005) 1077-1082
33. Pharoah P.D., Antoniou A.C., Easton D.F., and Ponder B.A. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358 (2008) 2796-2803
34. Covar R., Szefler S., Martin R., Sundstrom D., Silkoff P., Murphy J., et al. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 142 (2003) 469-475
35. Jatakanon A., Lim S., Kharitonov S., Chung K., and Barnes P. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 53 (1998) 91-95
36. Berlyne G.S., Parameswaran K., Kamada D., Efthimiadis A., and Hargreave F.E. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 106 (2000) 638-644
37. Berry M.A., Shaw D.E., Green R.H., Brightling C.E., Wardlaw A.J., and Pavord I.D. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy 35 (2005) 1175-1179
38. Chan-Yeung M., Obata H., Dittrick M., Chan H., and Abboud R. Airway inflammation, exhaled nitric oxide, and severity of asthma in patients with western red cedar asthma. Am J Respir Crit Care Med 159 (1999) 1434-1438
39. Mattes J., Storm van's Gravesande K., Reining U., Alving K., Ihorst G., Henschen M., et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur Respir J 13 (1999) 1391-1395
40. Payne D.N., Adcock I.M., Wilson N.M., Oates T., Scallan M., and Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 164 (2001) 1376-1381
41. Jones S.L., Kittelson J., Cowan J.O., Flannery E.M., Hancox R.J., McLachlan C.R., et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 164 (2001) 738-743
42. Pijnenburg M.W., Hofhuis W., Hop W.C., and De Jongste J.C. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 60 (2005) 215-218